Primary dysmenorrhea: alleviation by an inhibitor of prostaglandin synthesis and action.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004412:Dysmenorrhea / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005439:Flufenamic Acid / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors*; D010298:Parity; D010919:Placebos; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D062367:ortho-Aminobenzoates / Q000494:pharmacology / Q000627:therapeutic use*
D010919:Placebos; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D062367:ortho-Aminobenzoates; D005439:Flufenamic Acid; D006899:Mixed Function Oxygenases